Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
76 Ergebnisse
| FC0L37 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 39,000 | 39,000 | 2,774 | 34,247 % | - | Société Générale | ||
| FC6P8W | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 61,086 | 61,086 | 19,220 | 2,990 % | - | Société Générale | ||
| FC9LWW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 54,432 | 54,432 | 9,791 | 8,229 % | - | Société Générale | ||
| FD1P8L | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 35,872 | 40,200 | 2,474 | 32,223 % | - | Société Générale | ||
| FE5W9E | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 41,203 | 46,170 | 3,264 | 22,158 % | - | Société Générale | ||
| FG07TY | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 47,901 | 53,380 | 5,103 | 10,002 % | - | Société Générale | ||
| FG0DU0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 48,388 | 48,388 | 4,990 | 18,418 % | - | Société Générale | ||
| FG0DU1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 50,403 | 50,403 | 5,982 | 15,022 % | - | Société Générale | ||
| FG0DU2 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 52,417 | 52,417 | 7,331 | 11,625 % | - | Société Générale | ||
| FG0DUZ | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 46,374 | 46,374 | 4,232 | 21,814 % | - | Société Générale | ||
| FG0W62 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 56,427 | 56,427 | 13,055 | 4,865 % | - | Société Générale | ||
| FG1RYU | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 58,419 | 58,419 | 28,830 | 1,506 % | - | Société Générale | ||
| FG1VX1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 49,575 | 55,380 | - | 6,630 % | - | Société Générale | ||
| GG0DRZ | Biomarin Pharmaceutical Inc./Faktor/Short [5]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65,352 | 62,657 | 4,708 | 5,639 % | - | Goldman Sachs | ||
| GG4VK6 | Biomarin Pharmaceutical Inc./Faktor/Long [2]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 27,230 | 50,244 | 1,987 | 15,290 % | - | Goldman Sachs | ||
| GK8V7F | Biomarin Pharmaceutical Inc./Faktor/Short [2]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 81,690 | 67,977 | 1,963 | 14,608 % | - | Goldman Sachs | ||
| GU8SM5 | Biomarin Pharmaceutical Inc./Faktor/Long [10]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 53,199 | 57,337 | 6,403 | 3,331 % | - | Goldman Sachs | ||
| GU8WZL | Biomarin Pharmaceutical Inc./Faktor/Long [4]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 44,333 | 54,677 | 3,998 | 7,815 % | - | Goldman Sachs | ||
| GU8X1H | Biomarin Pharmaceutical Inc./Faktor/Short [10]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65,021 | 60,883 | 6,399 | 2,649 % | - | Goldman Sachs | ||
| GV6L9A | Biomarin Pharmaceutical Inc./Faktor/Long [5]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 43,568 | 55,563 | 5,021 | 6,320 % | - | Goldman Sachs | ||
| GW1DM7 | Biomarin Pharmaceutical Inc./Faktor/Short [4]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 73,888 | 63,543 | 3,845 | 7,133 % | - | Goldman Sachs | ||
| GW1GEZ | Biomarin Pharmaceutical Inc./Faktor/Short [3]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 78,813 | 65,021 | - | 9,625 % | - | Goldman Sachs | ||
| GW6MFU | Biomarin Pharmaceutical Inc./Faktor/Long [3]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 39,407 | 53,199 | - | 10,307 % | - | Goldman Sachs | ||
| GW6ZHR | Biomarin Pharmaceutical Inc./Faktor/Long [15]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 55,169 | 57,928 | - | 2,334 % | - | Goldman Sachs | ||
| GW7BXW | Biomarin Pharmaceutical Inc./Faktor/Short [15]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 63,051 | 60,292 | - | 1,652 % | - | Goldman Sachs | ||
| LX9Q43 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 30,035 | 30,035 | 2,063 | 42,130 % | - | Lang & Schwarz | ||
| LX9Q44 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 32,037 | 32,037 | 2,316 | 38,272 % | - | Lang & Schwarz | ||
| LX9Q45 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 34,039 | 34,039 | 2,425 | 34,414 % | - | Lang & Schwarz | ||
| LX9Q46 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36,041 | 36,041 | 2,758 | 30,556 % | - | Lang & Schwarz | ||
| LX9Q47 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 38,044 | 38,044 | 3,066 | 26,698 % | - | Lang & Schwarz | ||
| LX9Q48 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40,046 | 40,046 | 3,384 | 22,840 % | - | Lang & Schwarz | ||
| LX9Q49 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 42,048 | 42,048 | 3,919 | 18,982 % | - | Lang & Schwarz | ||
| LX9Q5A | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44,051 | 44,051 | 4,299 | 15,124 % | - | Lang & Schwarz | ||
| LX9Q5B | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 46,053 | 46,053 | 5,429 | 11,266 % | - | Lang & Schwarz | ||
| LX9Q5C | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48,055 | 48,055 | 6,515 | 7,408 % | - | Lang & Schwarz | ||
| LX9Q5D | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 50,058 | 50,058 | 8,406 | 3,550 % | - | Lang & Schwarz | ||
| LX9Q61 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48,046 | 48,046 | 6,507 | 7,426 % | - | Lang & Schwarz | ||
| LX9Q6V | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36,035 | 36,035 | 2,736 | 30,569 % | - | Lang & Schwarz | ||
| LX9Q6X | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40,038 | 40,038 | 3,270 | 22,855 % | - | Lang & Schwarz | ||
| LX9Q6Z | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44,042 | 44,042 | 4,281 | 15,140 % | - | Lang & Schwarz | ||
| LX9RZ6 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52,000 | 52,000 | - | -0,193 % | - | Lang & Schwarz | ||
| LX9RZ7 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52,000 | 52,000 | - | -0,193 % | - | Lang & Schwarz | ||
| LX9SD0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52,000 | 52,000 | - | -0,193 % | - | Lang & Schwarz | ||
| LX9SHK | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52,000 | 52,000 | - | -0,193 % | - | Lang & Schwarz | ||
| MG69UR |  | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44,598 | 48,170 | 3,992 | 18,786 % | - | Morgan Stanley | |
| MJ1B3S | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 79,457 | 79,457 | 2,984 | 33,964 % | - | Morgan Stanley | |
| MJ1BZ9 | | Biomarin Pharmaceutical Inc./Faktor/Long [4]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44,343 | 44,343 | 3,999 | 25,239 % | - | Morgan Stanley | |
| MJ27ZH | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 80,955 | 74,470 | 2,772 | 25,556 % | - | Morgan Stanley | |
| MJ5AYN | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 46,222 | 46,222 | - | 22,069 % | - | Morgan Stanley | |
| MK4BHP | | Biomarin Pharmaceutical Inc./Faktor/Long [3]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 39,416 | 39,416 | 3,003 | 33,546 % | - | Morgan Stanley |